Cancer Therapy
Researchers describe findings in cancer therapy studies
Published in Clinical Oncology Week, April 4th, 2005
Study 1: Silibinin limits doxorubicin-induced toxicity in murine tumor models.
"The acute and cumulative dose-related toxicity and drug resistance, mediated via nuclear factor kappa B (NFkappaB), of anthracycline anticancer drugs pose a major problem in cancer chemotherapy," according to scientists in the United States.
"Here, we report that oral silibinin (a flavanone) suppresses human non-small-cell lung carcinoma A549 xenograft growth (p=0.003) and enhances the therapeutic response (p<0.05) of doxorubicin in athymic BALB/c nu/nu...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
More Articles from Clinical Oncology Week
- Carcinogenesis
Multistage theory of carcinogenesis refined - Head and Neck Cancer
Dendritic cells mature in presence of tumor cells from head and neck cancer - Melanoma Vaccine
Melanoma-associated antigen mimotope inhibits melanoma cell growth - Oncology
Bone-specific metastatic phenotypes identified as clinically relevant - Smoking
Impact of dietary factors on cancer screening in Japan examined - Acute Leukemia
Liposomal amphotericin B safe and effective for fungal infection treatment - More from this issue of Clinical Oncology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
